Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2003-01-16
2008-03-11
Chernyshev, Olga N. (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S007500, C435S007700, C435S007900, C438S501000, C438S503000
Reexamination Certificate
active
07341844
ABSTRACT:
The invention relates to the use of Reelin as a marker for diagnosing psychiatric conditions. The disclosed tools and techniques can facilitate the diagnosis of psychiatric disorders including major depression, bipolar disorder, schizophrenia and autism.
REFERENCES:
patent: 3817827 (1974-06-01), Benz
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3901654 (1975-08-01), Gross
patent: 4098876 (1978-07-01), Piasio et al.
Tabor et al., 2001, Am J. Human Genetics, 69, No. 4, pp. 576.
DSM-IV, Fourth Edition, APSA, 1994, Washington DC, Table of contents, three pages.
Ausubel et al. (eds.), “Chapter 11: Immunology,”Short Protocols in Molecular Biology, Fourth Edition, 1999, John Wiley & Sons, Inc., New York, pp. 11-1-11-30.
Cole et al., “The EBV-Hybridoma Technique and Its Application to Human Lung Cancer,”Monoclonal Antibodies and Cancer Therapy, Reisfeld and Sell (eds.), 1985, Alan R. Liss, Inc., New York, pp. 77-96.
Cote et al., “Generation of human monoclonal antibodies reactive with cellular antigens,”Proc. Natl. Acad. Sci. USA, 1983, 80:2026-2030.
de Bergeyck et al., “A panel of monoclonal antibodies against reelin, the extracellular matrix protein defective in reeler mutant mice,”J. Neurosci. Meth., 1998, 82:17-24.
Fatemi et al., “Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression,”Molecular Psychiatry, 2000, 5:654-663.
Fatemi, “Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly,”Mol Psychiatry, 2001, 6:129-133.
Fatemi et al., “Altered levels of Reelin and its isoforms in schizophrenia and mood disorders,”NeuroReport, 2001, 12(15):3209-3215.
Guidotti et al., “Decrease in Reelin and Glutamic Acid Decarboxylase67(GAD67) Expression in Schizophrenia and Bipolar Disorder,”Arch. Gen. Psychiatry, 2000, 57:1061-1069.
Guidotti et al., “New Neurochemical Markers for Psychosis: A Working Hypothesis of Their Operation,”Neurochemical Res., 2000, 25(9/10):1207-1218.
Hong et al., “Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with humanRELNmutations,”Nature Genetics, 2000, 26:93-96.
Huse et al., “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda,”Science, 1989, 246:1275-1281.
Ikeda and Terashima, “Expression ofreelin, the Gene Responsible for the Reeler Mutation, in Embryonic Development and Adulthood in the Mouse,”Developmental Dynamics, 1997, 210 :157-172.
Impagnatiello et al., “A decrease of reelin expression as a putative vulnerability factor in schizophrenia,”Proc. Natl. Acad. Sci, USA, 1998, 95:15718-15723.
Köhler and Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity,”Nature, 1975, 256:495-497.
Kozbor and Roder, “The production of monoclonal antibodies from human lymphocytes,”Immunology Today, 1983, 4(3):72-79.
Lacor et al., “Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation,”Proc. Natl. Acad. Sci. USA, 2000, 97(7):3556-3561.
Lord et al., “Autism Diagnostic Interview-Revised: A Revised Version of a Diagnostic Interview for Caregivers of Individuals with Possible Pervasive Developmental Disorders,”J. Autism Dev. Disorders, 1994, 24(5):659-685.
Ogawa et al., “ThereelerGene-Associated Antigen on Cajal-Retzius Neurons Is a Crucial Molecule for Laminar Organization of Cortical Neurons,”Neuron, 1995, 14:899-912.
Persico et al., “Reelin gene allcles and haplotypes as a factor predisposing to autistic disorder,”Mol. Psychiatry, 2001, 6:150-159.
Smalheiser et al., “Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells,”Proc. Natl. Acad. Sci. USA, 2000, 97(3):1281-1286.
Stokstad, “New Hints Into the Biological Basis of Autism,”Science, 2001, 294:34-37.
Fatemi et al., “Reduced Blood Levels of Reelin as a Vulnerability Factor in Pathophysiology of Autistic Disorder”,Cellular and Molecular Neurobiology, 2002, 22(2):139-152.
Fatemi et al., “Dysregulation of Reelin and Bcl-2 Proteins in Autistic Cerebellum”,Journal of Autism and Developmental Disorders, 2001, 31(6):529-535.
Fatemi et al., “Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice”,Molecular Psychiatry, 1999, 4:145-154.
Fatemi, “The role of Reelin in pathology of autism”,Molecular Psychiatry, 2002, 7:919-920.
Chernyshev Olga N.
Fish & Richardson P.C.
Regents of the University of Minnesota
LandOfFree
Methods for diagnosing autism does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for diagnosing autism, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagnosing autism will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3980824